Company: SLDE
Filing Date: 2025-01-22
Form Type: DRS/A
Source: 0000950123-25-000502
Chunk: 190

Company: Slide Insurance Holdings, Inc.
Filing Date: 2025-01-22
Form: DRS/A
Chunk 190
---
 all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding.

Other rights.The holders of our common stock have no preemptive or conversion rights or other subscription rights. There are no
redemption or sinking fund provisions applicable to the common stock. Further, our Stockholders Agreement will provide that, until the Substantial Ownership Requirement is no longer met, any redemption, repurchase or other acquisition of ownership
interests (other than in connection with terms of equity compensation plans, subject to certain specified exceptions) must be approved by the Pre-IPO Significant Stockholders.

Preferred Stock

Our board of directors
has the authority to issue the preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption,
redemption prices, liquidation preferences and the number of shares constituting any series or the designation of such series, without further vote or action by the stockholders.

The issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of Slide without further action
by the stockholders and may adversely affect the voting and other rights of the holders of common stock. At present, Slide has no plans to issue any of the preferred stock.

133

Series A preferred stock As of September 30, 2024, we had 9,340,750 shares of Series A preferred stock outstanding. As a result of this offering, all the outstanding shares of the Series A preferred stock will be automatically converted into 9,340,750 shares of common stock. See Note 23, Shareholders Equity, to our financial statements included elsewhere in this prospectus. Warrants Common stock warrants As of the date of this prospectus, there are no warrants to purchase our common stock outstanding. Preferred stock warrants In December 2021, we issued an aggregate of 120,334 warrants to purchase shares of our Series A preferred stock in a private offering, which expire in December, 2028. Each of the warrants entitles the registered holder to purchase one share of our Series A preferred stock at an exercise price of $0.01 per share for cash, or on a cashless basis, subject to adjustment in certain circumstances. All of the preferred stock warrants were exercised on September 27, 2024, and, as a result, there are no warrants to purchase shares of our Series A preferred stock outstanding as of the date of this prospectus